Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
dmLT Adjuvant with fIPV for Polio Mucosal Immunity
NCT05327426Phase 1Unknown
- Sponsor
- The University of Vermont
- Start
- Apr 2022
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dmLT in poliomyelitis (2 arms), sponsored by The University of Vermont. Primary endpoint: Mucosal immunity to poliovirus at 4 months. Status: unknown.
02
Drugs
dmLT
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT05327426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05327426.